Lifeng Yu, Ying He, Guojia Liu, Qian Wei, Ruili Wang, Tongjie Wen et al. A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis. // Acta Pharmaceutica Sinica B. – 2026. – DOI: 10.1016/j.apsb.2026.06.055. – URL: https://doi.org/10.1016/j.apsb.2026.06.055
Lifeng Yu, Ying He, Guojia Liu, Qian Wei, Ruili Wang, Tongjie Wen, Jingqiu Chen, Qing Gao, Weitao Wang, Hualin Bai, Yan Wang, Chen Fu, Zhaojin Yu, Lin Zhao, & Minjie Wei (2026). A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.06.055
Lifeng Yu, et al. “A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis.” Acta Pharmaceutica Sinica B, 2026. doi:10.1016/j.apsb.2026.06.055.
@article{Yu2026,
title = {A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis},
author = {Yu, Lifeng and He, Ying and Liu, Guojia and Wei, Qian and Wang, Ruili and Wen, Tongjie and Chen, Jingqiu and Gao, Qing and Wang, Weitao and Bai, Hualin and Wang, Yan and Fu, Chen and Yu, Zhaojin and Zhao, Lin and Wei, Minjie},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.06.055},
url = {https://doi.org/10.1016/j.apsb.2026.06.055}
}